{"transactions":[{"id":961509,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2025-12-22T21:05:28.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":3685815,"price":0.0001,"value":368.5815,"ownership":{"direct":false,"nature":"By Corvus Capital Ltd."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 8, 2025, CDT Equity Inc. (the \"Company\") and Corvus Capital Limited (\"Corvus\") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the \"Pre-Funded Warrants\"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Until exercised in full."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On December 8, 2025, CDT Equity Inc. (the \"Company\") and Corvus Capital Limited (\"Corvus\") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the \"Pre-Funded Warrants\"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 8, 2025, CDT Equity Inc. (the \"Company\") and Corvus Capital Limited (\"Corvus\") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the \"Pre-Funded Warrants\"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares of Common Stock are owned of record by Corvus."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, including with respect to the Pre-Funded Warrant Shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":3685815,"derivative":{"exercise_price":0.0001,"exercise_date":"2025-12-08","underlying":"Common Stock","underlying_shares":3685815},"source":{"system":"sec-edgar","filing":"0001493152-25-028761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315225028761/ownership.xml","form_type":"4"}},{"id":961508,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:05:28.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":224800,"price":1.79,"value":402392.0,"ownership":{"direct":false,"nature":"By Corvus Capital Ltd."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 8, 2025, CDT Equity Inc. (the \"Company\") and Corvus Capital Limited (\"Corvus\") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the \"Pre-Funded Warrants\"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Based on the closing price per share of Common Stock on December 7, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares of Common Stock are owned of record by Corvus."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, including with respect to the Pre-Funded Warrant Shares, except to the extent of its or his pecuniary interest therein."}],"balance_after":227304,"source":{"system":"sec-edgar","filing":"0001493152-25-028761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315225028761/ownership.xml","form_type":"4"}},{"id":1112502,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T11:17:07.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":154799,"price":3.23,"value":500000.77,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Based on the closing price per share of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares of Common Stock are owned of record by Manoira Corporation (\"Manoira\"). On June 3, 2025, the Issuer issued 154,799 shares of Common Stock to Manoira pursuant to that certain joint development agreement (the \"Joint Development Agreement\") by and between the Issuer and Manoira, representing an up-front consideration of $500,000."}],"balance_after":154799,"source":{"system":"sec-edgar","filing":"0001641172-25-014963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225014963/ownership.xml","form_type":"4"}},{"id":1402819,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":1514100,"price":0.2583,"value":391092.03,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.255-0.265, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range. Following the sales of shares of Common Stock as reported in this Form 4, Algo no longer holds 10% of the outstanding shares of Common Stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":177627,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402818,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-16","kind":"sale","planned":false,"acquired":false,"shares":10244392,"price":0.3169,"value":3246447.8248,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.247-0.405, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":1691727,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402817,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-15","kind":"sale","planned":false,"acquired":false,"shares":1005200,"price":0.2471,"value":248384.92,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.223-0.276, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":11936119,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402816,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-12","kind":"sale","planned":false,"acquired":false,"shares":1389820,"price":0.2471,"value":343424.522,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.266-0.303, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":12941319,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402815,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-11","kind":"sale","planned":false,"acquired":false,"shares":300000,"price":0.29,"value":87000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.279-0.307, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":14331139,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402814,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-11","kind":"sale","planned":false,"acquired":false,"shares":582952,"price":0.2972,"value":173253.3344,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.290-0.307, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":14631139,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402813,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-10","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":0.3338,"value":50070.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.307-0.371, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":15214091,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402812,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-09","kind":"sale","planned":false,"acquired":false,"shares":77681,"price":0.4358,"value":33853.3798,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.426-0.452, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":15364091,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402811,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-08","kind":"sale","planned":false,"acquired":false,"shares":35923,"price":0.51,"value":18320.73,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":15441772,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402810,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-07-03","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":0.64,"value":640.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are owned solely by Algo. On March 26, 2024, Algo pledged certain shares of Common Stock to a financial institution as collateral for a loan, pursuant to that certain Control and Restricted Loan Agreement, dated March 26, 2024, by and between Algo and such financial institution (the \"Loan Agreement\"). The loan proceeds were used to pay a portion of certain amounts due to a third party investor in the Issuer as an inducement to such investment to the Issuer in September 2023, pursuant to an agreement entered into by and among Algo, Corvus and such third party. These shares of Common Stock were sold by such financial institution pursuant to the terms and conditions of the Loan Agreement."}],"balance_after":15477695,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402809,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-06-14","kind":"other","planned":false,"acquired":true,"shares":1100000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 14, 2024, Corvus Capital Limited (\"Corvus\") transferred 1,100,000 shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), to Algo Holdings, Inc. (\"Algo\"), its wholly-owned subsidiary for no consideration, pursuant to that certain Securities Transfer Request dated June 13, 2024. After giving effect to the transfer, Algo directly held 15,478,695 shares of Common Stock as of June 14, 2024. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein. This transfer reflects a change in the form of beneficial ownership and did not result in any change in Dr. Regan's and Corvus's pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On June 14, 2024, Corvus Capital Limited (\"Corvus\") transferred 1,100,000 shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), to Algo Holdings, Inc. (\"Algo\"), its wholly-owned subsidiary for no consideration, pursuant to that certain Securities Transfer Request dated June 13, 2024. After giving effect to the transfer, Algo directly held 15,478,695 shares of Common Stock as of June 14, 2024. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein. This transfer reflects a change in the form of beneficial ownership and did not result in any change in Dr. Regan's and Corvus's pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":15478695,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}},{"id":1402808,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":1036,"kind":"person","name":"Regan Andrew","position":1,"cik":"0001991325","reported_name":"Regan Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71040,"kind":"organization","name":"Corvus Capital Ltd.","position":2,"cik":"0001990829","reported_name":"Corvus Capital Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87401,"kind":"organization","name":"Algo Holdings, Inc.","position":3,"cik":"0001991236","reported_name":"Algo Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-19T21:01:44.000Z","date":"2024-06-14","kind":"other","planned":false,"acquired":false,"shares":1100000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 14, 2024, Corvus Capital Limited (\"Corvus\") transferred 1,100,000 shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), to Algo Holdings, Inc. (\"Algo\"), its wholly-owned subsidiary for no consideration, pursuant to that certain Securities Transfer Request dated June 13, 2024. After giving effect to the transfer, Algo directly held 15,478,695 shares of Common Stock as of June 14, 2024. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein. This transfer reflects a change in the form of beneficial ownership and did not result in any change in Dr. Regan's and Corvus's pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On June 14, 2024, Corvus Capital Limited (\"Corvus\") transferred 1,100,000 shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), to Algo Holdings, Inc. (\"Algo\"), its wholly-owned subsidiary for no consideration, pursuant to that certain Securities Transfer Request dated June 13, 2024. After giving effect to the transfer, Algo directly held 15,478,695 shares of Common Stock as of June 14, 2024. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein. This transfer reflects a change in the form of beneficial ownership and did not result in any change in Dr. Regan's and Corvus's pecuniary interest in such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. Algo is a wholly owned subsidiary of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by each of Corvus and Algo. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":30048454,"source":{"system":"sec-edgar","filing":"0001493152-24-037150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224037150/ownership.xml","form_type":"4"}}]}